000 01730 a2200493 4500
005 20250515074447.0
264 0 _c20080724
008 200807s 0 0 eng d
022 _a0167-6806
024 7 _a10.1007/s10549-007-9676-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUrruticoechea, Ander
245 0 0 _aPre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cJun 2008
300 _a463-70 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAromatase Inhibitors
_xpharmacology
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBiopsy, Needle
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCyclin D
650 0 4 _aCyclins
_xanalysis
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aKi-67 Antigen
_xanalysis
650 0 4 _aLetrozole
650 0 4 _aMice
650 0 4 _aNitriles
_xpharmacology
650 0 4 _aPeptides
_xanalysis
650 0 4 _aPostmenopause
650 0 4 _aReceptors, Estrogen
_xanalysis
650 0 4 _aTrefoil Factor-1
650 0 4 _aTriazoles
_xpharmacology
700 1 _aAguilar, Helena
700 1 _aSolé, Xavier
700 1 _aCapellà, Gabriel
700 1 _aMartin, Lesley-Ann
700 1 _aDowsett, Mitch
700 1 _aGermà-Lluch, Josep Ramon
773 0 _tBreast cancer research and treatment
_gvol. 109
_gno. 3
_gp. 463-70
856 4 0 _uhttps://doi.org/10.1007/s10549-007-9676-7
_zAvailable from publisher's website
999 _c17172448
_d17172448